• 2014

Company Description

ODIN Biotech Partners, LLC is a development-stage biotechnology company focused on developing novel peptide therapeutics

ODIN Biotech Partners, LLC is a development-stage biotechnology company focused on developing novel peptide therapeutics for diseases of the retina. ODIN’s lead product, C16Y, is currently in preclinical development for the treatment of wet age-related macular degeneration (AMD). ODIN expects to begin clinical studies of C16Y in early 2016.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2014
  • Company Website:

  • Company E-mail:

  • Company Address:

    3401 Armstrong Ave.
    Dallas, TX
    United States
  • CEO:

    • Karl Csaky
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits